期刊文献+

丙戊酸对癫痫患儿骨代谢的影响 被引量:7

The effect of valproate on bone metabolism in children with epilepsy
下载PDF
导出
摘要 目的:研究丙戊酸对癫痫患者骨代谢的影响。方法:癫痫患者组34例于丙戊酸治疗前、治疗后3个月及6个月分别测定血钙(Ca)、血磷(P)、骨性碱性磷酸酶(BAP)、骨钙素(BGP)、甲状旁腺素(PTH)、1,25-二羟维生素D3[1,25-(OH)2VitD3]、降钙素(CT)及尿脱氧吡啶啉(DPD)、肌酐(Cr);并设正常对照组30例。结果:两组治疗前骨代谢无显著差异;治疗组治疗后3个月、6个月CT、BAP、BGP、DPD、Cr均较治疗前明显升高(P<0.05),1,25-(OH)2VitD3较治疗前明显下降(P<0.05)。结论:丙戊酸治疗癫痫患儿可致骨代谢异常,骨形成及骨吸收均明显活跃。 Objective: To study the effect of valproate on bone metabolism in children with epilepsy. Methods: Calcium (Ca), phosphorum (P), bone alkaline phosphate (BAP), bone carboxyglutamate protein (BGP), parathormone (PTH), 1,25-(OH)2VitD3, calcitonin (CT) in serum and deoxypyridinoline (DPD), creatinine (Cr) in urine were measured in 34 epilepsy children treated with valproate before and 3 or 6 months after the treatment, so did in the control group of 30 healthy children. Results: There was no significant difference in bone metabolism between the therapy and the control group before the treatment. Ca, P and PTH serums levels showed no significant changes 3 or 6 months after the treatment while the CT, BAP, BGP, DPD,Cr were higher and 1,25-(OH)2VitD3 serum levels were lower than that be fore the treatment(P 〈 0.05). Conclusion: Valproate treatment in epileply activates bone resorption and bone formation, which lead to abnormal bone metabolism.
出处 《儿科药学杂志》 CAS 2005年第6期5-7,共3页 Journal of Pediatric Pharmacy
关键词 丙戊酸 癫痫 骨代谢 儿童 Valproate Epilepsy Bone metabolism Children
  • 相关文献

参考文献8

二级参考文献40

  • 1陈治卿.不同抗癫痫药对骨密度影响[J].中国骨质疏松杂志,1998,4(4):67-68. 被引量:11
  • 2刘中厚.骨质疏松学[M].北京:科学出版社,1998.142-143.
  • 3[1]ROBINS SP.Collagen crosslinks in metabolic bone disease[J].Acta Orthop Scand( Suppl266) ,1995,66:171-175.
  • 4[2]ROBINS SP,DUNCAN A,WILSON N,et al.Standardization of pyridinium crosslinks,pyridinoline and deoxypyridinoline,for use as biochemical markers of collagen degradation[J].Clin Chem,1996,42:1621-1626.
  • 5[3]ROBINS SP,BLACK D,PARTERSON CR,et al.Evaluation of urinary hydroxypyridinium crosslink measuremeants as resorption markers in metabolic bone diseases[J].Eur J Clin Invest,1991,21:310-315.
  • 6[4]DAVID R EYRE, THOMAS J KOOB,KIRK P VAN NESS. Quantitation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography[J].CAL Biochemistry ,1984,137: 380-388.
  • 7[5]SEBEL MJ,ROBINS SP,BILEZIKIAN JP.Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease[J].Treads Endocrinol Metab,1992,3:263-270.
  • 8[6]BIENKOWSKI RS.Intracellular degradation of newly synthesixed collagen[J].Collagen Rel Res,1984,4:399-412.
  • 9[7]BLACK D,DUNCAN A,ROBINS SP.Quantitative analytical of the pyridinium crosslinks of collagen in urine using ion paired reversed ph ase high performance liquid chromatography[J].Anal Biochem,1988, 169:197-203.
  • 10[8]PRATT DA,DANILOFF Y,DUNCAN A,et al.Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid phase extraction and reversed phase high performance liquid chromatography [J].Anal Biochem, 1992,207:168-175.

共引文献26

同被引文献82

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部